Posted January 07, 2018 05:25:52 Why do we need sex?
The world of treatment for sexual dysfunction has grown tremendously in recent years, with a huge number of treatments available.
These treatments range from new methods of treating sexual dysfunction to the more traditional methods of contraception.
But a new paper published in the Journal of Sexual Medicine points to a possible solution to sexual dysfunction: a new form of androgen-like growth factor-1 (androgen-G2F)-1 receptor agonist.
And the solution is not only new but it’s not a prescription pill: androgen therapy, which is commonly referred to as androgen replacement therapy (ARTS), is the treatment of choice for people with androgen insensitivity disorder.
Androgen therapy can be used to treat a wide range of conditions, including obesity, cardiovascular disease, and endometriosis.
In the new study, Dr. Juhana T. Olfa, a professor of pediatrics at the University of Chicago and the author of the paper, and her colleagues showed that people with male pattern baldness had significantly higher levels of the receptor forandrogen and its growth factor1 (G-1F)-2, indicating that androgen receptors play an important role in their androgenetic disorders.
The authors also found that patients with androgynous hair and facial hair had lower levels ofandrogen receptors.
And there was no difference between the groups for age, gender, race, or ethnicity.
The researchers also found no differences in the size or distribution of the G-1s.
Dr. Oefa explained that the discovery of the androgen receptor, as well as the increase in androgen treatments, may be a sign that the world is moving toward a better understanding of how androgen affects our bodies and how we respond to treatment.
“We are moving away from treating symptoms and towards treating disease,” she said.
“And the fact that we have more androgen therapies available for people that have androgenic disorders may be one of the reasons for this.”
Olfa said that this research provides new hope to patients struggling with and endocrine dysfunction.
“The idea that androgens could be an alternative to the traditional treatment for androgyny is exciting because it provides us with a new way to treat these patients, and it has a large number of benefits that we know we can’t replicate using traditional treatments,” she explained.
And as we look toward the future, Dr Olfab said that the next step for this research is to look at how androgens interact with other proteins in the body.
“It is clear that we are not just dealing with a problem of endocrine and sexual dysfunctions,” she concluded.
“But if we can find new and different ways to improve the quality of life, and the quality and safety of treatment, we may be able to help people in other ways.”
This article was originally published by The Conversation.
Read the original article.